Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission ...

Regeneron last year won European Commission approval of odronextamab as Ordspono for relapsed/refractory follicular lymphoma or diffuse large B-cell lymphoma after two or more lines of systemic ...

FDA decision expected by July 30, 2025TARRYTOWN, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) ...

Studies reveal that over 50% of food samples in India have pesticide residues beyond safe limits, linking them to increased ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

Irene Felux Brewer, born on May 30, 1953, in Floresville, Texas, passed away peacefully at South Arkansas Regional Hospital on Wednesday, Feb. 19, 2025, after a long battle with Non- Hodgkin’s ...

Horton was also named the Texans’ Ed Block Courage award winner in balloting from his teammates. The award is one of the most ...

The FDA cleared the investigational new drug application for LTZ-301, a first-in-class myeloid engager immunotherapy, with a ...

FDA clears LTZ's IND application to initiate trial of its myeloid engager immunotherapy to treat relapsed or refractory non-Hodgkin lymphoma.

Dan Bongino, podcaster and commentator, has been appointed deputy director of the FBI by President Donald Trump. Bongino, a ...

Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative ...

Odronextamab demonstrated a manageable safety profile and generated durable responses in patients with R/R DLBCL who have ...